QHSLab, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a USAQ research report →
Companywww.usaqcorp.com
QHSLab, Inc. , a medical device technology and software as a service (SaaS) company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine. It also develops digital therapeutics and point of care solutions to support remote patient monitoring, address chronic care, and preventive medicine.
- CEO
- Troy James Grogan
- IPO
- 2013
- Employees
- 4
- HQ
- West Palm Beach, FL, US
Price Chart
Valuation
- Market Cap
- $6.38M
- P/E
- 18.05
- P/S
- 2.30
- P/B
- 5.14
- EV/EBITDA
- 8.99
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 66.08%
- Op Margin
- 1.76%
- Net Margin
- 15.61%
- ROE
- 91.63%
- ROIC
- 2.96%
Growth & Income
- Revenue
- $2.69M · 26.26%
- Net Income
- $457.42K · 276.45%
- EPS
- $0.04 · 258.73%
- Op Income
- $131.24K
- FCF YoY
- 25.05%
Performance & Tape
- 52W High
- $1.14
- 52W Low
- $0.08
- 50D MA
- $0.62
- 200D MA
- $0.44
- Beta
- 0.44
- Avg Volume
- 2.84K
Get TickerSpark's AI analysis on USAQ
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 29, 26 | Marvin Smollar Family Trust dtd 2/13/2023 | other | 0 |
| Dec 31, 21 | Grogan Troy James | other | 2,644,424 |
| Sep 1, 19 | Grogan Troy James | other | 1,080,092 |
| Sep 30, 20 | Grogan Troy James | other | 88,016 |
| Feb 27, 20 | Grogan Troy James | other | 1 |
| Feb 20, 20 | Grogan Troy James | other | 0 |
| Dec 27, 19 | Grogan Troy James | other | 161,138 |
| Sep 1, 19 | Grogan Troy James | other | 5,400,460 |
| Oct 9, 09 | Grogan Troy James | other | 76,000,000 |
| Aug 5, 19 | Grogan Troy James | other | 500,000 |
Our USAQ Coverage
We haven't published any research on USAQ yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate USAQ Report →